How many 8-K filings has Enveric Biosciences, Inc. filed?

Enveric Biosciences, Inc. (ENVB) has 31 8-K (Current Event Report) filings on record, spanning Jan 2024 to Dec 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Enveric Biosciences, Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Enveric Biosciences, Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Enveric Biosciences, Inc. (ENVB) — 8-K Filings

All 8-K filings from Enveric Biosciences, Inc.. Browse 31 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (31)

8-K Filing — Dec 12, 2025
Enveric Biosciences Files 8-K on Shareholder Votes & Exhibits — Dec 11, 2025 Risk: low
Enveric Biosciences, Inc. filed an 8-K on December 11, 2025, reporting on matters submitted to a vote of security holders and financial statements/exhibits. The
Enveric Biosciences Faces Delisting Concerns — Oct 23, 2025 Risk: high
Enveric Biosciences, Inc. filed an 8-K on October 23, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The company's stock
Enveric Biosciences Files 8-K: Material Agreement & Equity Sales — Sep 18, 2025 Risk: medium
Enveric Biosciences, Inc. announced on September 17, 2025, that it entered into a material definitive agreement. The company also reported on unregistered sales
Enveric Biosciences Files 8-K — Sep 2, 2025 Risk: low
Enveric Biosciences, Inc. filed an 8-K on September 2, 2025, reporting on various events. The filing includes information related to Regulation FD Disclosure, O
Enveric Biosciences Faces Delisting Notice — Aug 29, 2025 Risk: high
Enveric Biosciences, Inc. filed an 8-K on August 26, 2025, to report a notice of delisting or failure to satisfy a continued listing rule. The company, previous
Enveric Biosciences Files 8-K on Financials — Aug 14, 2025 Risk: low
Enveric Biosciences, Inc. filed an 8-K on August 14, 2025, reporting on its results of operations and financial condition. The filing includes financial stateme
Enveric Biosciences Files 8-K on Shareholder Votes & Financials — Jun 3, 2025 Risk: low
Enveric Biosciences, Inc. filed an 8-K on May 29, 2025, reporting on matters submitted to a vote of security holders and financial statements. The company, inco
Enveric Biosciences Appoints New Auditor — Apr 14, 2025 Risk: medium
Enveric Biosciences, Inc. filed an 8-K on April 14, 2025, to report changes in its certifying accountant. The company has appointed Marcum LLP as its new indepe
Enveric Biosciences Files 8-K on Financials — Mar 31, 2025 Risk: low
Enveric Biosciences, Inc. filed an 8-K on March 31, 2025, reporting on its results of operations and financial condition. The filing includes financial statemen
Enveric Biosciences Files 8-K — Mar 6, 2025 Risk: low
Enveric Biosciences, Inc. filed an 8-K on March 6, 2025, reporting an event that occurred on March 4, 2025. The filing is categorized under 'Other Events' and d
Enveric Biosciences Files 8-K — Feb 26, 2025 Risk: low
Enveric Biosciences, Inc. filed an 8-K on February 26, 2025, reporting information under Regulation FD and including financial statements and exhibits. The comp
Enveric Biosciences Files 8-K, Reports Material Agreement — Feb 3, 2025 Risk: medium
Enveric Biosciences, Inc. filed an 8-K on February 3, 2025, reporting an entry into a material definitive agreement and other events. The filing details the com
Enveric Biosciences Files 8-K on Security Holder Matters — Jan 21, 2025 Risk: medium
Enveric Biosciences, Inc. filed an 8-K on January 21, 2025, reporting on events that occurred on January 17, 2025. The filing indicates material modifications t
Enveric Biosciences Files 8-K with Financials — Jan 3, 2025 Risk: low
Enveric Biosciences, Inc. filed an 8-K on January 3, 2025, reporting information under Regulation FD and including financial statements and exhibits. The compan
Enveric Biosciences Faces Delisting Notice — Nov 22, 2024 Risk: high
Enveric Biosciences, Inc. filed an 8-K on November 20, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company is base
Enveric Biosciences Enters Material Definitive Agreement — Nov 12, 2024 Risk: medium
Enveric Biosciences, Inc. announced on November 7, 2024, that it entered into a material definitive agreement. The company, previously known as Ameri Holdings,
Enveric Biosciences Files 8-K — Aug 22, 2024 Risk: low
Enveric Biosciences, Inc. filed an 8-K on August 22, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly kno
Enveric Biosciences Enters Material Definitive Agreement — Jul 15, 2024 Risk: medium
Enveric Biosciences, Inc. announced on July 10, 2024, that it entered into a material definitive agreement. The company, previously known as Ameri Holdings, Inc
Enveric Biosciences Files 8-K on Shareholder Votes & Financials — May 29, 2024 Risk: low
Enveric Biosciences, Inc. filed an 8-K on May 28, 2024, reporting on matters submitted to a vote of security holders and financial statements. The company, form
Enveric Biosciences Faces Delisting Notice — May 23, 2024 Risk: high
Enveric Biosciences, Inc. filed an 8-K on May 23, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company is based in
Enveric Biosciences Faces Delisting Concerns — May 17, 2024 Risk: high
Enveric Biosciences, Inc. filed an 8-K on May 17, 2024, to report a notice of delisting or failure to satisfy a continued listing rule or standard. The company,
Enveric Biosciences Files 8-K for Material Agreement — May 3, 2024 Risk: medium
Enveric Biosciences, Inc. filed an 8-K on May 3, 2024, reporting the entry into a material definitive agreement. The filing also includes financial statements a
Enveric Biosciences Files 8-K on Shareholder Nominations — Mar 28, 2024 Risk: medium
Enveric Biosciences, Inc. filed an 8-K on March 28, 2024, to report shareholder nominations pursuant to Exchange Act Rule 14a-11. The filing details the company
Enveric Biosciences Files 8-K — Mar 19, 2024 Risk: low
Enveric Biosciences, Inc. filed an 8-K on March 19, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contai
Enveric Biosciences Files 8-K for Material Agreement — Mar 11, 2024 Risk: medium
Enveric Biosciences, Inc. filed an 8-K on March 11, 2024, reporting an entry into a material definitive agreement and financial statements. The filing date for
Enveric Biosciences Files 8-K for Regulation FD and Financials — Feb 29, 2024 Risk: low
Enveric Biosciences, Inc. filed an 8-K on February 29, 2024, to disclose information under Regulation FD and provide financial statements and exhibits. The fili
Enveric Biosciences Files 8-K on Feb 21, 2024 — Feb 21, 2024 Risk: low
Enveric Biosciences, Inc. filed an 8-K on February 21, 2024, under Regulation FD Disclosure and Financial Statements and Exhibits. The filing indicates a curren
Enveric Biosciences (ENVB) Delisted from Nasdaq — Feb 9, 2024 Risk: high
Enveric Biosciences, Inc. (ENVB) announced on February 6, 2024, that its common stock, par value $0.01 per share, will be delisted from The Nasdaq Stock Market.
Enveric Biosciences Reports Exit/Disposal Costs — Jan 8, 2024
Enveric Biosciences, Inc. filed an 8-K on January 8, 2024, reporting 'Cost Associated with Exit or Disposal Activities.' This filing indicates that the company
Enveric Biosciences Files Routine 8-K, Confirms Nasdaq Listing — Jan 3, 2024
Enveric Biosciences, Inc. filed an 8-K on January 3, 2024, primarily to disclose general company information and confirm its registration on The Nasdaq Stock Ma

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX